Animal and Human Imaging Shared Resource
动物和人类成像共享资源
基本信息
- 批准号:10682585
- 负责人:
- 金额:$ 25.17万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1998
- 资助国家:美国
- 起止时间:1998-09-01 至 2025-08-31
- 项目状态:未结题
- 来源:
- 关键词:AddressAnimal Cancer ModelAnimal ExperimentationAnimal ModelAnimalsBreastCancer Center Support GrantClinicalClinical TrialsCollaborationsDataData AnalysesDedicationsDevelopmentEffectivenessEnsureEnvironmentEquipmentEventExperimental DesignsFacultyFundingGoalsGood Manufacturing ProcessHealthcareHistologyHumanImageImage AnalysisImaging TechniquesIndividualInstitutionInvestigational DrugsInvestigational New Drug ApplicationIsotopesMagnetic ResonanceMagnetic Resonance ImagingMalignant NeoplasmsMentorshipMethodsMissionModalityMolecularMonitorNon-Invasive DetectionNuclearOpticsPET/CT scanPatientsPhasePhysiciansPositron-Emission TomographyPreparationProductionProteomicsProtocols documentationRadiochemistryRadiopharmaceuticalsReproducibilityResearchResearch PersonnelResource SharingResourcesScientistServicesSpecialized Program of Research ExcellenceStudentsSystemTalentsThe Vanderbilt-Ingram Cancer Center at the Vanderbilt UniversityTimeTracerTrainingUltrasonographyUniversitiesanimal imagingbiomedical imagingcancer clinical trialcancer imagingclinical imagingclinically relevantdesignexperimental studygastrointestinalhuman imaginghuman modelimagerimaging facilitiesimaging modalityimaging probeimaging scienceimaging scientistimaging studyimaging systemimprovedin vivoinnovationinstrumentmethod developmentmultimodalitynon-invasive imagingnovelpre-clinicalprecision oncologyprogramsquantitative imagingresponseresponsible research conductsingle photon emission computed tomographytumortumor metabolismultrasound
项目摘要
CORE 002 – ANIMAL AND HUMAN IMAGING SHARED RESOURCE
PROJECT SUMMARY/ABSTRACT
The Animal and Human Imaging Shared Resource (AHISR) has been continuously supported by the Cancer
Center Support Grant (CCSG) since 2004. The AHISR provides scientific and technical assistance for
experiments employing biomedical imaging for the study of cancer in both the pre-clinical and clinical settings
and continues to undertake developments to meet ongoing needs. As in previous cycles, the AHISR remains a
critical component of VICC’s Specialized Programs of Research Excellence (SPORE) programs, with both
recently renewed Breast and Gastrointestinal (GI) SPOREs having featured imaging components. In 2018, the
AHISR was integral to landing a new NCI-funded co-clinical imaging trial resource (U24) focused on quantitative
PET imaging of cancer metabolism with investigational radiopharmaceuticals. Furthermore, the AHISR expertise
and capabilities have enabled a new partnership between VICC and GE Health Care (GEHC), where quantitative
cancer imaging and radiopharmaceutical discovery are central pillar programs of a major precision oncology
initiative. The faculty and staff within the AHISR provide access to state-of-the-art imaging facilities including
advanced human MRI systems operating at 3T and 7T, a research-dedicated PET/CT, ultrasound scanner, and
a comprehensive facility for multimodal animal imaging and research radiopharmaceuticals for animal and
human use. Furthermore, the AHISR leverages the institutional resources within the Vanderbilt University
Institute of Imaging Science (VUIIS) to develop new and improved methods for obtaining information that
addresses research questions of direct cancer relevance. More specifically, the AHISR will provide:
1. Collaborations with expert imaging science faculty (in nuclear, optical, magnetic resonance and
ultrasound imaging) for the development and application of cutting-edge imaging protocols
2. Innovative and novel radiopharmaceuticals for animal and human imaging research
3. Support for imaging system operators and technical staff who will handle patient and animal preparation
and monitoring as well as operate the instruments
4. Support for data analysis and for quantitative image analysis customized to specific applications including
the co-registration and integration of multiple modalities, histology and proteomics.
The AHISR brings together advanced equipment and diverse expertise into a comprehensive integrated
resource that ensures the quality of the imaging data, and consequently, the overall quality, rigor, and
reproducibility of the studies is the highest possible.
核心002 - 动物和人类成像共享资源
项目摘要/摘要
动物和人类成像共享资源(AHISR)一直受到癌症的不断支持
自2004年以来
在临床前和临床环境中,采用生物医学成像研究癌症的实验
并继续进行发展以满足持续的需求。与以前的周期一样,AHISR仍然是
VICC专业的研究卓越计划(Spore)计划的关键组成部分,两者都
最近,具有成像成分的乳房和胃肠道(GI)孢子。在2018年
AHISR是降落新的NCI资助的共同成像试验资源(U24)不可或缺的一部分
使用研究放射性药物的癌症代谢的宠物成像。此外,AHISR专业知识
能力和能力已经在VICC和GE Health Care(GEHC)之间建立了新的合作伙伴关系,
癌症成像和放射药物发现是主要精确肿瘤学的中心支柱程序
倡议。 AHISR中的教职员工提供了对最新成像设施的访问
高级人类MRI系统在3T和7T上运行,一项研究的PET/CT,超声扫描仪和
用于动物和动物的多模式动物成像和研究放射性药物的全面设施
人使用。此外,AHISR利用范德比尔特大学内的机构资源
成像科学研究所(VUIIS)开发新的和改进的方法,以获取信息
解决了直接癌症相关性的研究问题。更具体地说,AHISR将提供:
1。与专家成像科学教师合作(核,光学,磁共振和
超声成像)用于开发和应用尖端成像协议
2。动物和人类成像研究的创新和新颖的放射性药物
3.支持成像系统操作员和技术人员,他们将处理患者和动物准备
和监视以及操作仪器
4。支持数据分析和定量图像分析,定制为特定应用程序,包括
多种方式,组织学和蛋白质组学的共同注册和整合。
AHISR将高级设备和潜水专业知识融合在一起,成为全面的综合综合
确保成像数据质量的资源,从而确保整体质量,严谨和
研究的可重复性最高。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Todd E Peterson其他文献
Todd E Peterson的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Todd E Peterson', 18)}}的其他基金
cGMP Compliant HPLC for Radiopharmaceutical Quality Control
用于放射性药物质量控制的符合 cGMP 的 HPLC
- 批准号:
10430807 - 财政年份:2022
- 资助金额:
$ 25.17万 - 项目类别:
Automated Cassette-Based Radiosynthesis Equipment
基于盒的自动化放射合成设备
- 批准号:
10177621 - 财政年份:2021
- 资助金额:
$ 25.17万 - 项目类别:
Enabling Multi-Tracer SPECT Studies of the Human Brain
实现人脑的多示踪剂 SPECT 研究
- 批准号:
9789299 - 财政年份:2018
- 资助金额:
$ 25.17万 - 项目类别:
Synthetic-Collimator SPECT with Semiconductor Detectors
带有半导体探测器的合成准直器 SPECT
- 批准号:
9251554 - 财政年份:2011
- 资助金额:
$ 25.17万 - 项目类别:
Synthetic-Collimator SPECT with Semiconductor Detectors
带有半导体探测器的合成准直器 SPECT
- 批准号:
8461601 - 财政年份:2011
- 资助金额:
$ 25.17万 - 项目类别:
Synthetic-Collimator SPECT with Semiconductor Detectors
带有半导体探测器的合成准直器 SPECT
- 批准号:
8162426 - 财政年份:2011
- 资助金额:
$ 25.17万 - 项目类别:
Synthetic-Collimator SPECT with Semiconductor Detectors
带有半导体探测器的合成准直器 SPECT
- 批准号:
8300089 - 财政年份:2011
- 资助金额:
$ 25.17万 - 项目类别:
Synthetic-Collimator SPECT with Semiconductor Detectors
带有半导体探测器的合成准直器 SPECT
- 批准号:
8661579 - 财政年份:2011
- 资助金额:
$ 25.17万 - 项目类别:
相似国自然基金
APOBEC3A驱动膀胱癌发生发展的动物模型及其机制研究
- 批准号:82303057
- 批准年份:2023
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
输卵管来源卵巢低级别浆液性癌动物模型建立及HOXA5相关分子通路在其发生发展中的作用和机制研究
- 批准号:81902654
- 批准年份:2019
- 资助金额:21.0 万元
- 项目类别:青年科学基金项目
Slug参与CP-31398介导的p53突变型子宫内膜癌细胞凋亡的机制研究
- 批准号:81702967
- 批准年份:2017
- 资助金额:19.0 万元
- 项目类别:青年科学基金项目
建立小鼠模型研究人纤维板层肝细胞癌(FLHCC)
- 批准号:81773304
- 批准年份:2017
- 资助金额:84.0 万元
- 项目类别:面上项目
基于转录组和microRNA分析中国地鼠口腔黏膜癌发生的表观遗传学机制
- 批准号:31772551
- 批准年份:2017
- 资助金额:58.0 万元
- 项目类别:面上项目
相似海外基金
Core 1: Animal Models, Pathology and Tissue
核心 1:动物模型、病理学和组织
- 批准号:
10713715 - 财政年份:2023
- 资助金额:
$ 25.17万 - 项目类别:
Advancement of the Xiphophorus Model for Studying Disease
研究疾病的剑尾动物模型的进展
- 批准号:
10805701 - 财政年份:2023
- 资助金额:
$ 25.17万 - 项目类别:
Speckle x-ray imaging: detecting early changes in lung microstructure
散斑 X 射线成像:检测肺微结构的早期变化
- 批准号:
10560958 - 财政年份:2023
- 资助金额:
$ 25.17万 - 项目类别:
32nd International Workshop on Retroviral Pathogenesis
第32届逆转录病毒发病机制国际研讨会
- 批准号:
10587287 - 财政年份:2022
- 资助金额:
$ 25.17万 - 项目类别:
Development of a Frontier Magnetic Resonance (MR) Imaging Technology As a Tool for Visualization and Quantified Vascular-Feature Measurement for Use in Brain and Behavioral Research on Small Animals
开发前沿磁共振 (MR) 成像技术作为可视化和量化血管特征测量的工具,用于小动物的大脑和行为研究
- 批准号:
10384839 - 财政年份:2022
- 资助金额:
$ 25.17万 - 项目类别: